Jove
Visualize
Contact Us

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Anatomy in Aesthetic Gluteal Contouring.

Clinics in plastic surgery·2018
Same author

Autologous Gluteal Augmentation with the Moustache Transposition Flap Technique.

Clinics in plastic surgery·2018
Same author

Preface.

Clinics in plastic surgery·2018
Same author

Facial aesthetic surgery in the setting of localized heat-induced urticaria.

Aesthetic surgery journal·2014
Same author

DMSO: applications in plastic surgery.

Aesthetic surgery journal·2009
Same author

Gluteal aesthetic unit classification: a tool to improve outcomes in body contouring.

Aesthetic surgery journal·2009
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 24, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Botulinum toxin a for managing focal hyperhidrosis.

Robert F Centeno

    Aesthetic Surgery Journal
    |April 2, 2009
    PubMed
    Summary

    Botulinum toxin (Botox) injections offer a safe and effective treatment for focal hyperhidrosis, providing long-lasting relief for 8-9 months with high patient satisfaction.

    Area of Science:

    • Dermatology
    • Medical Aesthetics

    Background:

    • Focal hyperhidrosis is a condition characterized by excessive sweating in specific body areas.
    • Current treatments for hyperhidrosis can have limitations in efficacy or duration.

    Purpose of the Study:

    • To evaluate the safety, efficacy, and patient satisfaction of botulinum toxin (Botox) for treating focal hyperhidrosis.
    • To determine the duration of therapeutic effect for Botox in hyperhidrosis management.

    Main Methods:

    • The study involved patients diagnosed with focal hyperhidrosis.
    • Botulinum toxin injections were administered to the affected areas.
    • Patient outcomes, including symptom improvement, complication rates, and satisfaction, were assessed.

    Main Results:

    More Related Videos

    A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
    10:30

    A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

    Published on: December 27, 2013

    Related Experiment Videos

    Last Updated: Jun 24, 2026

    Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
    07:05

    Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

    Published on: November 9, 2016

    A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
    10:30

    A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

    Published on: December 27, 2013

    • Botox demonstrated a safe, rapid, and effective treatment profile for focal hyperhidrosis.
    • The treatment yielded uniformly good results with a low incidence of complications.
    • High levels of patient satisfaction were reported.
    • The therapeutic effects of Botox were observed to persist for an average of 8 to 9 months.

    Conclusions:

    • Botulinum toxin (Botox) is a well-tolerated and effective therapeutic option for focal hyperhidrosis.
    • The long duration of action and high patient satisfaction support the use of Botox for this condition.